Target intelligence / Profile preview

Interferon-induced GTP-binding protein Mx1 (MX1)

Target
MX1
Molecular classification
Enzyme, Large GTPase, Dynamin superfamily
01

Overview

Interferon-induced GTP-binding protein Mx1 (MX1) is a cytoplasmic large GTPase of the dynamin superfamily, primarily induced by type I and II interferons. It plays a critical role in the innate immune response by providing resistance to a wide range of RNA and DNA viruses, including influenza and hepatitis B. MX1 acts by binding and sequestering viral components, thereby inhibiting different stages of the viral life cycle and blocking replication. It is regarded as a major effector in the antiviral interferon-induced pathway, and variations in its expression or function can influence susceptibility to viral infections[1][3][4][7][8].

Other names
Interferon-induced protein p78Myxoma resistance protein 1Myxovirus resistance protein 1IFI-78KIFI78MxAlncMX1-215MXMxInterferon-regulated resistance GTP-binding protein MxA
02

Mechanism of action

Antiviral mechanism—binds and inactivates viral ribonucleocapsids, prevents nuclear import or encases viral nucleoprotein in cytoplasmic complexes to block virus amplification and egress

03

Biological functions

Antiviral immune responseInhibition of viral replicationGTP hydrolysisModulation of stress-mediated cell death
04

Disease associations

Infection, particularly viral infection (e.g., influenza, rabies, hepatitis B)
05

Safety considerations

Overactivation may enhance ER stress-mediated cell deathPotential for heightened immune or inflammatory responses in some contexts
06

Biomarkers

Potentially MX1 protein (MxA) levels as a marker for type I/III interferon activity and host antiviral state

Beyond the preview

Go deeper on Interferon-induced GTP-binding protein Mx1 (MX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon-induced GTP-binding protein Mx1 (MX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call